throbber
Paper No. ____
`
`Filed: September 21, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`INNOPHARMA LICENSING, INC., INNOPHARMA LICENSING LLC,
`INNOPHARMA INC., INNOPHARMA LLC,
`MYLAN PHARMACEUTICALS INC., and MYLAN INC.,
`
`Petitioner
`
`v.
`
` SENJU PHARMACEUTICAL CO., LTD., BAUSCH & LOMB, INC., and
`BAUSCH & LOMB PHARMA HOLDINGS CORP.,
`Patent Owner
`_________________
`Case IPR2015-00902 (Patent 8,669,290 B2)
`
`
`
`
`
`
`PATENT OWNER’S MOTION TO EXPUNGE
`UNDER 37 C.F.R. § 42.56
`
`
`
`
`
`

`
`
`I.
`
`Statement of Relief Requested
`
`Case IPR2015-00902
`Patent No. 8,669,290
`
`Pursuant to 37 C.F.R. § 42.56, Patent Owner requests that the Board
`
`expunge from the record the confidential versions of Paper Nos. 33, 34, and 91 and
`
`Exs. 1082, 1081, 1079, 1150, 2082, 2096, 2102, 2103, 2110, 2116, 2130, 2249-54,
`
`2258-2263, and 2273, for the reasons stated herein.
`
`II. Background
`On July 29, 2016, Patent Owner filed a Renewed Motion to Seal concerning
`
`a number of Patent Owner’s exhibits, listed below (see Paper No. 96), and on
`
`August 1, 2016, Patent Owner filed a Second Renewed Motion to Seal concerning
`
`additional exhibits, also listed below, (see Paper No. 98). On August 29, 2016, the
`
`Board granted Patent Owner’s two motions to seal (see Paper Nos. 99, 101),
`
`sealing all or portions of the following papers and exhibits:
`
`• Patent Owner’s Response (citing to confidential exhibits), Paper Nos. 33 and
`
`34 (filed December 28, 2015), and 91 (filed July 29, 2016).1
`
`
`1 Paper 91 was a revised, confidential version of the Patent Owner’s Response,
`
`filed on July 29, 2016, to conform with the marking requirements of the Default
`
`Protective Order, which the parties requested that the Board enter on July 29, 2016,
`
`and to remove redactions to information (specifically expert testimony) which
`
`Patent Owner no longer sought to seal.
`
`
`
`2
`
`

`
`
`
`Case IPR2015-00902
`Patent No. 8,669,290
`
`• Excerpts to Patent Owner’s New Drug Application: Ex. 2096 (filed July 29,
`
`2016); Ex. 2102 (filed July 29, 2016); Ex. 2103 (filed July 29, 2016); Ex.
`
`2110 (filed July 29, 2016)2.
`
`• Materials related to third-party BioScience’s testing procedures: Exs. 2249-
`
`54, 2258-2263 (filed April 6, 2016).
`
`• Expert Declarations: Williams (Ex. 2082) (filed July 29, 2016); Trattler (Ex.
`
`2116) (filed July 29, 2016); and Jarosz (Ex. 2130) (filed July 29, 2016).3
`
`• Transcripts of Expert Cross Examinations: Mr. Hofmann (Ex. 2273) (filed
`
`July 29, 2016); Dr. Paulson (Ex. 1082) (filed March 18, 2016); Dr. Trattler
`
`(Ex. 1081) (filed March 18, 2016); and Dr. Williams (Ex. 1079) (filed
`
`March 18, 2016).
`
`
`2 Revised, confidential versions of Exs. 2096, 2102, 2103, and 2110 were filed on
`
`July 29, 2016 to conform with the marking requirements of the Default Protective
`
`Order.
`
`3 Revised, confidential versions of Exs. 2082, 2116, and 2130 were filed on July
`
`29, 2016 to conform with the marking requirements of the Default Protective Order
`
`and to remove redactions to information (specifically expert testimony) which
`
`Patent Owner no longer sought to seal.
`
`
`
`3
`
`

`
`As outlined in the Joint Stipulation filed herewith, in its Final Written
`
`Case IPR2015-00902
`Patent No. 8,669,290
`
`
`
`Decision of July 28, 2016, the Board referred to paragraphs containing sealed,
`
`confidential information, in the following papers and exhibits:
`
`• Patent Owner’s Response (Paper No. 34),
`
`• Hofmann Declaration (Ex. 1150),
`
`• Williams Declaration (Ex. 2082),
`
`• Trattler Declaration (Ex. 2116), and
`
`• Jarosz Declaration (Ex. 2130).
`
`As also noted in the Joint Stipulation, the parties will file revised, public
`
`versions of Patent Owner’s Response and Exs. 1150, 2082, 2116, and 2130,
`
`leaving unredacted the portions of those papers and exhibits cited by the Board in
`
`the Final Written Decision.
`
`III. Reasons for the Relief Requested
`In the Board’s Order of September 19, 2016, the Board authorized an
`
`extension of time to file this Motion to Expunge. (See Paper No. 103.) In that
`
`same Order, the Board noted that it would not entertain a motion to expunge with
`
`respect to confidential information cited in the Board’s Final Written Decision. Id.
`
`at 3. Accordingly, Patent Owner requests the following papers and exhibits
`
`containing confidential information sealed by the Board, but not referred to in the
`
`Board’s Final Written Decision, be expunged from the record:
`4
`
`
`
`

`
`
`
`Case IPR2015-00902
`Patent No. 8,669,290
`
`• Patent Owner’s Response (citing the confidential information), Paper Nos.
`
`33 and 34 (filed December 28, 2015), and 91 (filed July 29, 2016).
`
`• Excerpts to Patent Owner’s New Drug Application: Ex. 2096 (filed July 29,
`
`2016); Ex. 2102 (filed July 29, 2016); Ex. 2103 (filed July 29, 2016); Ex.
`
`2110 (filed July 29, 2016).
`
`• Materials related to third-party BioScience’s testing procedures: Exs. 22494-
`
`54, 2258-2263 (filed April 6, 2016).5
`
`• Confidential versions of Expert Declarations: Hofmann (Ex. 1150);
`
`Williams (Ex. 2082); Trattler (Ex. 2116); and Jarosz (Ex. 2130).
`
`• Confidential versions of transcripts of Expert Cross Examinations: Mr.
`
`Hofmann (Ex. 2273) (filed July 29, 2016); Dr. Paulson (Ex. 1082) (filed
`
`March 18, 2016); Dr. Trattler (Ex. 1081) (filed March 18, 2016); and Dr.
`
`Williams (Ex. 1079) (filed March 18, 2016).
`
`Because the public has access to all the materials relevant to the merits of
`
`this proceeding, either through publicly filed papers and exhibits or through
`
`redacted, public versions of Patent Owner’s Response (Paper No. 34), Hofmann
`
`
`4 Only the confidential version of Ex. 2249 should be expunged.
`
`5 Patent Owner has been authorized by third party BioScience to make this request
`
`on its behalf. See Ex. 2279 at ¶ 9.
`
`
`
`5
`
`

`
`
`Declaration (Ex. 1150), Williams Declaration (Ex. 2082), Trattler Declaration (Ex.
`
`Case IPR2015-00902
`Patent No. 8,669,290
`
`2116), and the Jarosz Declaration (Ex. 2130) filed herewith, and given the sensitive
`
`and confidential nature of the sealed information (including the BioScience
`
`information, see Ex. 2279 at ¶ 7), good cause exists for the Board to expunge the
`
`papers and exhibits listed above pursuant to 37 C.F.R. § 42.56.
`
`Moreover, Patent Owner submits that the exhibits listed above continue to
`
`contain confidential information and that expunging the them from the record will
`
`not hamper the public interest of maintaining a complete and understandable file
`
`history for public notice purposes. Patent Owner therefore requests the exhibits
`
`listed above be removed from the record.
`
`Patent Owner contacted counsel for Petitioner and they do not oppose this
`
`motion to expunge.
`
`IV. Conclusion
`For the reasons set forth above, Petitioner requests that the Board grant this
`
`motion and expunge confidential versions of Paper Nos. 33, 34, and 91, and Exs.
`
`1082, 1081, 1079, 1150, 2082, 2096, 2102, 2103, 2110, 2116, 2130, 2249-54,
`
`2258-2263, and 2273 from the record.
`
`
`Dated: September 21, 2016
`
`
`
`
`By: /Joshua L. Goldberg/
`Joshua L. Goldberg, Back-up Counsel
`Reg. No. 59,369
` Attorney for Patent Owner
`
`6
`
`

`
`CERTIFICATE OF SERVICE
`
`Case IPR2015-00902
`Patent No. 8,669,290
`
`
`The undersigned hereby certifies that a copy of the foregoing PATENT
`
`OWNER’S MOTION TO EXPUNGE UNDER 37 C.F.R. § 42.56 was served on
`
`September 21, 2016, via email directed to counsel of record for the Petitioner at the
`
`following:
`
`Jitendra Malik, Ph.D
`Jitty.malik@alston.com
`
`Bryan Skelton, Ph.D.
`Bryan.skelton@alston.com
`
`Lance Soderstrom
`Lance.soderstrom@alston.com
`
`Hitetada James Abe
`James.abe@alston.com
`
`Joseph M. Janusz
`Joe.janusz@alston.com
`
`
`
`
`
`
`
` /Bradley J. Moore/
`Bradley J. Moore
`Litigation Legal Assistant
`
`FINNEGAN, HENDERSON,
`FARABOW, GARRETT & DUNNER,
`LLP
`
`7
`
`
`
`
`
`
`
`
`
`Date: September 21, 2016

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket